Guardant Health, Inc.
NASDAQ:GH · NASDAQ Global Select
+$2.67 today
Vol 3.16M · Avg 2.21M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+171.43%
Period High
$133.22
Period Low
$40.98
Latest
$131.78
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Exact Sciences Corporation
EXAS
$20.03B
Viatris Inc.
NASDAQ:VTRS
$17.90B
Ascendis Pharma A/S
NASDAQ:ASND
$14.34B
Solventum Corporation
NYSE:SOLV
$13.07B
BridgeBio Pharma, Inc.
NASDAQ:BBIO
$12.98B
Ionis Pharmaceuticals, Inc.
NASDAQ:IONS
$12.25B
ICON Public Limited Company
NASDAQ:ICLR
$11.18B
Revvity, Inc.
NYSE:RVTY
$11.15B
Encompass Health Corporation
NYSE:EHC
$9.72B
Qiagen N.V.
NYSE:QGEN
$7.62B
What is the latest GH filing?
The latest filing shown is 4 dated Jun 17, 2026.
How many recent filings does GH have?
Intrinsic Alpha currently shows 20 recent filings for GH.
Explore More
Continue the stock analysis
Jump to another research area for this company.